Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells

被引:92
作者
Takakura, M
Kyo, S
Inoue, M
Wright, WE
Shay, JW
机构
[1] Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA
[2] Kanazawa Univ, Sch Med, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan
关键词
D O I
10.1128/MCB.25.18.8037-8043.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional regulation of the human telomerase catalytic subunit (hTERT) plays a critical role in telomerase activity. Approximately 200 by of the proximal core promoter is responsible for basic hTERT expression; however, the function of the distal regulatory elements remains unclear. The transcription factor activator protein 1 (AP-1) is involved in cellular proliferation, differentiation, carcinogenesis, and apoptosis and is expressed broadly in both cancer and normal cells. There are several putative AP-1 sites in the hTERT promoter, but their functions are unknown. The present study examined the regulatory role of AP-1 in hTERT gene transcription. Overexpression of AP-1 leads to transcriptional suppression of hTERT in cancer cells. The combination of c-Fos and c-Jun or c-Fos and JunD strongly suppresses hTERT promoter activity in transient-expression analyses. The hTERT promoter region between -2000 and -378 is responsible for this function. Gel shift and supershift analyses, as well as ChIP, show binding of JunD and c-Jun on two putative AP-1 sites within this region. Mutations in the AP-1 binding sites rescued suppressions caused by AP-1, suggesting this is a direct regulation of the hTERT promoter. In contrast, there was no effect on mTERT expression or mTERT promoter activity by AP-1 overexpression in mouse fibroblasts. The species-specific function of AP-1 in TERT expression may in part help explain the difference in telomerase activity between normal human and mouse cells.
引用
收藏
页码:8037 / 8043
页数:7
相关论文
共 47 条
[41]   Telomerase activation by histone deacetylase inhibitor in normal cells [J].
Takakura, M ;
Kyo, S ;
Sowa, Y ;
Wang, Z ;
Yatabe, N ;
Maida, Y ;
Tanaka, M ;
Inoue, M .
NUCLEIC ACIDS RESEARCH, 2001, 29 (14) :3006-3011
[42]  
Takakura M, 1998, CANCER RES, V58, P1558
[43]  
Tanaka H, 1998, GENE CHROMOSOME CANC, V23, P123, DOI 10.1002/(SICI)1098-2264(199810)23:2<123::AID-GCC5>3.0.CO
[44]  
2-4
[45]   EVIDENCE FOR A MITOTIC CLOCK IN HUMAN HEMATOPOIETIC STEM-CELLS - LOSS OF TELOMERIC DNA WITH AGE [J].
VAZIRI, H ;
DRAGOWSKA, W ;
ALLSOPP, RC ;
THOMAS, TE ;
HARLEY, CB ;
LANSDORP, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :9857-9860
[46]  
Yasumoto S, 1996, ONCOGENE, V13, P433
[47]   Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells [J].
Yi, XM ;
Shay, JW ;
Wright, WE .
NUCLEIC ACIDS RESEARCH, 2001, 29 (23) :4818-4825